Increased Mortality Seen With Empirical Anti-MRSA Treatment for Pneumonia Increased Mortality Seen With Empirical Anti-MRSA Treatment for Pneumonia
Empirical anti-MRSA treatment is associated with an increased risk of 30-day mortality in patients hospitalized for pneumonia, compared with standard antibiotic therapy, according to a retrospective study.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Pulmonary Medicine News Source Type: news
More News: Antibiotic Therapy | Infectious Diseases | MRSA | Pathology | Pneumonia | Study | Superbugs